PL1761495T3 - Analogi piperydynylo prostaglandyny jako hipotensyjne środki oczne - Google Patents

Analogi piperydynylo prostaglandyny jako hipotensyjne środki oczne

Info

Publication number
PL1761495T3
PL1761495T3 PL05749871T PL05749871T PL1761495T3 PL 1761495 T3 PL1761495 T3 PL 1761495T3 PL 05749871 T PL05749871 T PL 05749871T PL 05749871 T PL05749871 T PL 05749871T PL 1761495 T3 PL1761495 T3 PL 1761495T3
Authority
PL
Poland
Prior art keywords
prostaglandin analogs
hypotensive agents
ocular hypotensive
piperidinyl
piperidinyl prostaglandin
Prior art date
Application number
PL05749871T
Other languages
English (en)
Inventor
David W Old
Danny T Dinh
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of PL1761495T3 publication Critical patent/PL1761495T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms
    • C07D211/76—Oxygen atoms attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/59—Hydrogenated pyridine rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL05749871T 2004-06-04 2005-05-16 Analogi piperydynylo prostaglandyny jako hipotensyjne środki oczne PL1761495T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US57736104P 2004-06-04 2004-06-04
PCT/US2005/017167 WO2005121086A2 (en) 2004-06-04 2005-05-16 Piperidinyl prostaglandin analogs as ocular hypotensive agents
EP05749871A EP1761495B1 (en) 2004-06-04 2005-05-16 Piperidinyl prostaglandin analogs as ocular hypotensive agents

Publications (1)

Publication Number Publication Date
PL1761495T3 true PL1761495T3 (pl) 2012-07-31

Family

ID=35431920

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05749871T PL1761495T3 (pl) 2004-06-04 2005-05-16 Analogi piperydynylo prostaglandyny jako hipotensyjne środki oczne

Country Status (9)

Country Link
US (1) US7435746B2 (pl)
EP (1) EP1761495B1 (pl)
AT (1) ATE550323T1 (pl)
AU (1) AU2005252171A1 (pl)
CA (1) CA2569464C (pl)
DK (1) DK1761495T3 (pl)
ES (1) ES2381377T3 (pl)
PL (1) PL1761495T3 (pl)
WO (1) WO2005121086A2 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7326716B2 (en) * 2003-06-06 2008-02-05 Allergan, Inc. Treatment of inflammatory bowel disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2296122C2 (ru) * 2001-07-16 2007-03-27 Ф.Хоффманн-Ля Рош Аг Производные 2-пирролидона в качестве простаноидных агонистов и фармацевтическая композиция
WO2003047513A2 (en) * 2001-12-03 2003-06-12 Merck & Co., Inc. Method for treating ocular hypertension
AU2003207900A1 (en) * 2002-03-18 2003-09-29 Pfizer Products Inc. Methods of treatment with selective ep4 receptor agonists
US6573294B1 (en) * 2002-05-14 2003-06-03 Allergan, Inc. 8-azaprostaglandin analogs as agents for lowering intraocular pressure
CN1735597A (zh) * 2003-01-10 2006-02-15 霍夫曼-拉罗奇有限公司 作为前列腺素激动剂的2－哌啶酮衍生物
CA2528179C (en) * 2003-06-06 2013-10-22 Allergan, Inc. Piperidinyl prostaglandin e analogs

Also Published As

Publication number Publication date
EP1761495B1 (en) 2012-03-21
WO2005121086A3 (en) 2006-04-27
US20060281713A1 (en) 2006-12-14
CA2569464A1 (en) 2005-12-22
AU2005252171A1 (en) 2005-12-22
EP1761495A2 (en) 2007-03-14
ATE550323T1 (de) 2012-04-15
WO2005121086A2 (en) 2005-12-22
CA2569464C (en) 2012-10-23
ES2381377T3 (es) 2012-05-25
US7435746B2 (en) 2008-10-14
DK1761495T3 (da) 2012-06-18

Similar Documents

Publication Publication Date Title
ATE440603T1 (de) 8-hydroxychinolinderivate
NO20073357L (no) 5-karboksamid substituerte tiazol derivater som reagerer med ionekanaler, i saerdeleshet med ionekanaler fra Kv familien
WO2008012635A3 (en) Amine derivatives useful as anticancer agents
TW200630344A (en) Tetracyclic indole derivatives as antiviral agents
EA200870117A1 (ru) Азаиндоловые ингибиторы аурора-киназ
ATE440834T1 (de) Substituierte arylaminderivate und verwendungsverfahren
EA200601350A1 (ru) Азотсодержащие гетероциклические производные и их фармацевтические применения
ATE517882T1 (de) Chinolinderivate
BRPI0413876A (pt) tienopiridin-fenilacetamidas e seus derivados úteis como agentes antiangiogênicos
DOP2001000170A (es) Derivados de tiofeno utiles como agentes anticancesoros
CL2024000067A1 (es) Compuestos antivirales
PA8580301A1 (es) Nuevos derivados de benzoimidazol utiles como agentes antiproliferativos
TW200728260A (en) Substituted-(quinazolinyl)phenyl thiophenyl-sulfonylureas, methods for making and intermediates thereof
MX2009003874A (es) Derivados de espiro-oxindol triciclicos y sus usos como agentes terapeuticos.
SE0400284D0 (sv) Novel compounds
ATE372995T1 (de) Benzo(b)(1,4)dioxepinderivate
CO2024013702A2 (es) Derivados de pirido-[3,4-d]piridazina amina útiles como derivados de nlrp3
DK1753723T3 (da) Substituerede quinolinderivater som mitotiske kinesininhibitorer
UY27803A1 (es) Derivados de benzoxazina y usos de los mismos.
JOP20250214A1 (ar) مشتقات هيدروكينازولين لعلاج مرض أو اضطراب
MXPA05005790A (es) Aminoalcoxiindoles como ligandos del receptor 5-ht6 para el tratamiento de enfermedades del sistema nervioso central.
EA200701780A1 (ru) Противоопухолевое средство
MX2009007040A (es) Derivados de mononitrato de isosorbida para el tratamiento de hipertension ocular.
BRPI0407400A (pt) derivados do ácido 10,10-dialquil prostanóico como agentes para o abaixamento de pressão intra-ocular
WO2004066952A3 (en) Benzoxazole, benzothiazole, and benzimidazole derivatives for the treatment of cancer and other diseases